Psyence Biomedical Income Statement (2023-2026) | PBM

Income Statement Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Operating items
Depreciation & Amortization - Total (Quarter) 0.00M-0.00M
Research & Development (Quarter) -0.01M0.27M0.36M
Wages, Salaries and Other (Quarter) 0.20M0.37M0.88M
Selling, General & Administrative (Quarter) -0.02M0.24M0.22M
Operating Expenses (Quarter) -0.02M0.51M0.57M
EBIT (Quarter) -3.23M-0.20M1.16M-1.51M
Non-operating items
Interest & Investment Income (Quarter) 0.03M0.07M
Other Non Operating Income (Quarter) 0.00M-0.10M636.00
Net income details
EBT (Quarter) -3.23M-0.18M1.16M-1.50M
Profit After Tax (Quarter) -3.21M0.31M0.14M-0.75M
Income from Continuing Operations (Quarter) -3.23M-0.18M1.16M-1.50M
Consolidated Net Income (Quarter) -3.23M-0.31M0.14M-1.50M
Income towards Parent Company (Quarter) -3.23M-0.31M0.14M-1.50M
Net Income towards Common Stockholders (Quarter) -3.23M-0.31M0.14M-1.50M
Additional items
EPS (Basic) (Quarter) -0.00M-177.060.03-6.35
EPS (Diluted) (Quarter) -0.00M-231.450.03-6.35
Shares Outstanding (Quarter) 0.00M0.00M0.00M5.56M0.03M0.24M0.55M
Shares Outstanding (Diluted) (Quarter) 0.00M0.00M0.00M5.56M0.03M0.24M0.55M
EBITDA (Quarter) -3.23M-0.20M1.16M-1.51M
Interest Expenses (Quarter) -0.03M0.00M-0.00M